Proactiveinvestors Australia Dynavax Technologies https://www.proactiveinvestors.com.au Proactiveinvestors Australia Dynavax Technologies RSS feed en Thu, 14 Nov 2019 07:57:44 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Dynavax announces layoffs, floats selloff of immuno-oncology arm https://www.proactiveinvestors.com.au/companies/news/220944/dynavax-announces-layoffs-floats-selloff-of-immuno-oncology-arm-220944.html Fri, 24 May 2019 15:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220944/dynavax-announces-layoffs-floats-selloff-of-immuno-oncology-arm-220944.html Dynavax Technologies shares climb after drug test to treat melanoma shows positive response rate https://www.proactiveinvestors.com.au/companies/news/207567/dynavax-technologies-shares-climb-after-drug-test-to-treat-melanoma-shows-positive-response-rate-207567.html Mon, 22 Oct 2018 12:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207567/dynavax-technologies-shares-climb-after-drug-test-to-treat-melanoma-shows-positive-response-rate-207567.html Dynavax shares set to rise on "encouraging' results of cancer drug https://www.proactiveinvestors.com.au/companies/news/195061/dynavax-shares-set-to-rise-on-encouraging-results-of-cancer-drug-195061.html Mon, 16 Apr 2018 13:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195061/dynavax-shares-set-to-rise-on-encouraging-results-of-cancer-drug-195061.html Dynavax shares skyrocket after its Hepatitis B drug gets US FDA advisory committee approval https://www.proactiveinvestors.com.au/companies/news/181717/dynavax-shares-skyrocket-after-its-hepatitis-b-drug-gets-us-fda-advisory-committee-approval-181717.html Mon, 31 Jul 2017 16:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181717/dynavax-shares-skyrocket-after-its-hepatitis-b-drug-gets-us-fda-advisory-committee-approval-181717.html Dynavax reports late stage drug trial, Q3 losses widen https://www.proactiveinvestors.com.au/companies/news/80925/dynavax-reports-late-stage-drug-trial-q3-losses-widen-20249.html Thu, 27 Oct 2011 15:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/80925/dynavax-reports-late-stage-drug-trial-q3-losses-widen-20249.html